DUBLIN, Ireland, July 15 /PRNewswire-FirstCall/ -- Trinity Biotech plc , a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of fiscal year 2008 on Tuesday, July 22, 2008. The Company has scheduled a conference call for that same day, Tuesday, July 22, 2008, at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.
A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=50024
The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=50024
About Trinity Biotech plc
Headquartered in Wicklow, Ireland, Trinity Biotech develops, acquires, manufactures and markets over 500 diagnostic products for the point-of-care and clinical laboratory segments of the diagnostic market. The broad line of test kits are used to detect infectious diseases, sexually transmitted diseases, blood coagulation disorders, and autoimmune diseases. Trinity Biotech sells worldwide in over 80 countries through its own sales force and a network of international distributors and strategic partners.
For further information please see the company’s website: http://www.trinitybiotech.com.
CONTACT: Ms. Niamh Long Investor Relations Officer, Trinity Biotech plc,
1-800-603-8076; or Joe Diaz, Joe Dorame and Robert Blum, all of Lytham
Partners, LLC, +1-602-889-7900, for Trinity Biotech plc
Web site: http://www.trinitybiotech.com/
